186 related articles for article (PubMed ID: 32598269)
1. Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats.
Saleh SR; Abady MM; Nofal M; Yassa NW; Abdel-Latif MS; Nounou MI; Ghareeb DA; Abdel-Monaem N
Curr Rev Clin Exp Pharmacol; 2021; 16(2):139-154. PubMed ID: 32598269
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study.
Soudi SA; Nounou MI; Sheweita SA; Ghareeb DA; Younis LK; El-Khordagui LK
Drug Deliv Transl Res; 2019 Oct; 9(5):906-919. PubMed ID: 30868509
[TBL] [Abstract][Full Text] [Related]
3. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats.
Hussien HM; Abd-Elmegied A; Ghareeb DA; Hafez HS; Ahmed HEA; El-Moneam NA
Food Chem Toxicol; 2018 Jan; 111():432-444. PubMed ID: 29170048
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of Saroglitazar on Scopolamine-Induced Alzheimer's in Rats: Insights into the Underlying Mechanisms.
Sandeep Ganesh G; Konduri P; Kolusu AS; Namburi SV; Chunduru BTC; Nemmani KVS; Samudrala PK
ACS Chem Neurosci; 2023 Sep; 14(18):3444-3459. PubMed ID: 37669120
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
7. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
Cells; 2021 May; 10(5):. PubMed ID: 34064687
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of Berberine Nanoparticles Against Seizures in Pentylenetetrazole Induced Kindling Model of Epileptogenesis: Role of Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Mechanisms.
Saha L; Kumari P; Rawat K; Gautam V; Sandhu A; Singh N; Bhatia A; Bhattacharya S; Sinha VR; Chakrabarti A
Neurochem Res; 2023 Oct; 48(10):3055-3072. PubMed ID: 37329447
[TBL] [Abstract][Full Text] [Related]
9. Investigating Neuroprotective Potential of Berberine, Levetiracetam and their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.
Singh A; Dhaneshwar S; Mazumder A
Curr Rev Clin Exp Pharmacol; 2023; 18(2):182-190. PubMed ID: 34515019
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling.
Wang YY; Yan Q; Huang ZT; Zou Q; Li J; Yuan MH; Wu LQ; Cai ZY
J Alzheimers Dis; 2021; 79(2):833-844. PubMed ID: 33361598
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia.
Ghotbi Ravandi S; Shabani M; Bashiri H; Saeedi Goraghani M; Khodamoradi M; Nozari M
Neurosci Lett; 2019 Jul; 706():151-157. PubMed ID: 31103726
[TBL] [Abstract][Full Text] [Related]
12. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats.
Hafez HS; Ghareeb DA; Saleh SR; Abady MM; El Demellawy MA; Hussien H; Abdel-Monem N
Psychopharmacology (Berl); 2017 Oct; 234(20):3037-3053. PubMed ID: 28733814
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression.
Ahrari A; Najafzadehvarzi H; Taravati A; Tohidi F
Life Sci; 2021 Nov; 284():119884. PubMed ID: 34389401
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: Impact on behavioral and biochemical parameters in rats.
Nanaware S; Shelar M; Sinnathambi A; Mahadik KR; Lohidasan S
Biomed Pharmacother; 2017 Sep; 93():543-553. PubMed ID: 28686968
[TBL] [Abstract][Full Text] [Related]
17. Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation.
He W; Wang C; Chen Y; He Y; Cai Z
Pharmacol Rep; 2017 Dec; 69(6):1341-1348. PubMed ID: 29132092
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory efficacy of Berberine Nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model.
Azadi R; Mousavi SE; Kazemi NM; Yousefi-Manesh H; Rezayat SM; Jaafari MR
BMC Pharmacol Toxicol; 2021 Oct; 22(1):54. PubMed ID: 34600570
[TBL] [Abstract][Full Text] [Related]
19. Biochemical profiling of berberine-enriched extract in aluminum chloride induced oxidative damage and neuroinflammation.
Akash MSH; Akbar M; Rehman K; Shah MA; Panichayupakaranant P; Imran M; Assiri MA
Environ Sci Pollut Res Int; 2023 Aug; 30(36):85263-85275. PubMed ID: 37380861
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats.
Pattanashetti LA; Taranalli AD; Parvatrao V; Malabade RH; Kumar D
Indian J Pharmacol; 2017; 49(1):60-64. PubMed ID: 28458424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
